最新ニュース Axion Ven (OTC:AXNVF) 株価情報

Axion Ventures Inc is an investment issuer with majority ownership in online video gaming and other IT sectors. The principal activities of the Group are principally engaged in game software development, game operation, provision of outsourcing services, software license and software training. The geographical presence of the company in Canada, China and Rest of the world.

AXION VENTURES INC by Axion Ventures Inc.

Axion Ventures Inc

Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. The company reported quarterly sales of $65.200 million which missed the analyst consensus estimate of $67.555 million by 3.49 percent. This is a 2.49 percent decrease over sales of $66.865 million the same period last year.

Earnings

Earnings Misses

News

MRVI

Maravai LifeSciences Q3 2024 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $65.200M Miss $67.555M Estimate

Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) System-wide sales are expected to be between $525 million and $535 million.

Guidance

JYNT

Joint Corp. FY 2024 System-wide sales are expected to be between $525 million and $535 million.

Updated FY2024 Guidance
&nbsp;
<ul>
<li>The Company is raising several components of its FY2024 guidance due to: 1) continued sustained growth, and 2) the inclusion of the newly launched banking program with WebBank, which was not accounted for in previous guidance.</li>
<li>&nbsp;
<ul>
<li>Net Income: $71.5 million versus $55.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Net Income per Diluted Share: $12.05 versus $9.25 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Growth: 55% versus 35%-40% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Less Transaction Related Costs as a percentage of Total Revenue: No change to the 55% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>Additionally, updating the FY2024 guidance for the following metrics that adjust for certain significant gains, losses, and charges that may not directly correlate to the underlying performance of the Company's business:</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income<a href="http:/#_ftn2">[2]</a>: $58.0 million versus $40.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income per Diluted Share2: $9.80 versus $6.75 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>The Company expects a mid-single digit annualized effective tax before consideration of discrete tax items for 4Q24.</li>
</ul>

SEZL

Sezzle Increases FY24 Revenue Growth Guidance From 35%-40% To 55%; Adj. Net Income Per Diluted Share From $6.75 To $9.80 Vs $6.73 Est.; Adj. Net Income From $40M To $58M

FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) lowers FY2024 sales outlook from $545.65 million-556.56 million to $540.19 million-545.65 million.

FIGS

FIGS Lowers FY2024 Sales Guidance from $545.65M-556.56M to $540.19M-545.65M

ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.79) by 26.58 percent.

Earnings Beats

ALXO

ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58) Beats $(0.79) Estimate

CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.31) by 93.55 percent. The company reported quarterly sales of $56.664 million which missed the analyst consensus estimate of $58.042 million by 2.37 percent. This is a 0.90 percent increase over sales of $56.157 million the same period last year.

CYRX

CryoPort Q3 2024 GAAP EPS $(0.02) Beats $(0.31) Estimate, Sales $56.664M Miss $58.042M Estimate

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $190.00 thousand which missed the analyst consensus estimate of $2.25 million by 91.56 percent. This is a 81.85 percent decrease over sales of $1.05 million the same period last year.

MVIS

Microvision Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales $190.00K Miss $2.25M Estimate

At current rates, the Company expects negligible year-over-year currency impact on the full year 2024 revenues.
Additionally, Artivion continues to expect adjusted EBITDA growth of between 28% and 34% for the full year 2024 compared to 2023 resulting in an expected range of $69 to $72 million for 2024.

AORT

Artivion Narrows FY24 Revenue Outlook From $388M -$396M To $389M - $396M, Est $391.955M

Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 8.33 percent. The company reported quarterly sales of $102.638 million which beat the analyst consensus estimate of $102.001 million by 0.62 percent. This is a 20.00 percent increase over sales of $85.532 million the same period last year.

Sprout Social Q3 2024 Adj. EPS $0.13 Beats $0.12 Estimate, Sales $102.638M Beat $102.001M Estimate

W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. The company reported quarterly sales of $121.372 million which missed the analyst consensus estimate of $122.406 million by 0.84 percent. This is a 14.77 percent decrease over sales of $142.411 million the same period last year.

W&T Offshore Q3 2024 Adj. EPS $(0.17) Beats $(0.19) Estimate, Sales $121.372M Miss $122.406M Estimate

Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.37) by 29.73 percent. The company reported quarterly sales of $26.03 million which missed the analyst consensus estimate of $34.37 million by 24.26 percent. This is a 74.03 percent increase over sales of $14.96 million the same period last year.

ACLX

Arcellx Q3 2024 GAAP EPS $(0.48) Misses $(0.37) Estimate, Sales $26.03M Miss $34.37M Estimate

Management

Natural Gas Services Group Announced The Appointment Of Ian Eckert As CFO Effective No Later Than January 5th, 2026. NGS's Current Interim CFO John Bittner Will Continue In that Role Until Mr. Eckert's Start Date

Con Edison CFO Kirk Andrews Says We Are Narrowing And Revising Our 2024 Adjusted EPS Guidance To The Upper Half Of Our Original Range

Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) sees Q4 sales of $40.000 million-45.000 million vs $50.03 million estimate.

CMBM

Cambium Networks Sees Q4 Sales $40.000M-45.000M vs $50.03M Est

SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $97.400 million which beat the analyst consensus estimate of $96.647 million by 0.78 percent. This is a 23.73 percent increase over sales of $78.718 million the same period last year.

SEMR

SEMrush Hldgs Q3 2024 GAAP EPS $0.01 Misses $0.03 Estimate, Sales $97.400M Beat $96.647M Estimate

Sandstorm Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAND#NYSE">SAND</a>) reported quarterly sales of $44.700 which missed the analyst consensus estimate of $44.900 million by 100.00 percent. This is a 100.00 percent decrease over sales of $41.324 million the same period last year.

SAND

Sandstorm Gold Q3 Sales $44.700 Miss $44.900M Estimate

nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $56.13 million which beat the analyst consensus estimate of $55.27 million by 1.55 percent. This is a 10.85 percent increase over sales of $50.63 million the same period last year.

LASR

nLight Q3 Adj $(0.08), Inline, Sales $56.13M Beat $55.27M Estimate

Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) is looking for Q2 Adj EPS of $0.30-0.40 vs $0.27 analyst estimate. sees sales of $380.000 million-400.000 million vs $354.32 million estimate.

LITE

Lumentum Holdings Sees Q2 Adj EPS $0.30-0.40 vs $0.27 Est; Sees Sales $380.000M-400.000M vs $354.32M Est

Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.62 by 3.7 percent.

Consolidated Edison Q3 2024 Adj. EPS $1.68 Beats $1.62 Estimate

PDF Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDFS#NASDAQ">PDFS</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.20 by 25 percent. The company reported quarterly sales of $46.409 million which beat the analyst consensus estimate of $46.196 million by 0.46 percent. This is a 9.58 percent increase over sales of $42.350 million the same period last year.

Comments

Axion Ven

ニュース

最新ニュース Axion Ven (OTC:AXNVF) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル